Skip to main content

Novel Methods and Pathways in Cancer Glycobiology Research

  • 1st Edition, Volume 157 - February 2, 2023
  • Editors: Charles J Dimitroff, Karen Abbott
  • Language: English
  • Hardback ISBN:
    9 7 8 - 0 - 3 2 3 - 9 9 1 7 7 - 3
  • eBook ISBN:
    9 7 8 - 0 - 3 2 3 - 9 9 1 7 8 - 0

Cancer glycobiology is a blazing hot area of cancer research with aberrant post-translational glycosylations on lipids and proteins considered critical for cancer development an… Read more

Novel Methods and Pathways in Cancer Glycobiology Research

Purchase options

Limited Offer

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Book bundle cover eBook and print

Institutional subscription on ScienceDirect

Request a sales quote

Cancer glycobiology is a blazing hot area of cancer research with aberrant post-translational glycosylations on lipids and proteins considered critical for cancer development and metastasis.  The NIH/NCI Alliance of Glycobiologists for Cancer Research is a consortium of (10) tumor glycobiology laboratories funded to investigate how cancer-associated glycans (CAG) impact the development and metastasis of cancer.  The hope of this momentous effort is to discover CAGs for use as novel biomarkers to detect early-stage cancer or its aggressive behavior or, alternatively, as novel molecular targets with the promise of a curative approach to cancer therapy.  The mission of the ‘Alliance’ is to study structure and function of CAGs in cancer development and to provide clinically useful biomarkers for detecting cancer early or the potential of metastasis.  This charge has stimulated extensive collaborations across US and International institutions to accelerate discovery of glycan-based biomarkers to the forefront of NCI's efforts to diagnose early-stage cancer and provide curative anti-cancer therapies. 

The main goals of these research efforts are:
1.  To identify and study how cancer-associated glycans functionally impact cancer growth and metastasis
2.  To identify cancer-associated glycans that can serve as biomarkers for the detection or progression of cancer
3.  To develop cancer-associated glycans as novel therapeutic targets for the treatment and cure of cancer

This volume consists of (9) chapters, one from each funded laboratory, that reviews new methods and mechanisms  highlighting glycoconjugates and their roles as cancer biomarkers and/or anti-cancer therapeutic targets.